Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion type Assertion NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_head.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_provenance.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion evidence source_evidence_literature NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_provenance.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion SIO_000772 15535838 NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_provenance.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion wasDerivedFrom befree-20140225 NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_provenance.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion wasGeneratedBy ECO_0000203 NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_provenance.